New drug aims to stop AML relapse after transplant
Disease control
Recruiting now
This study tests whether the drug mocravimod can help prevent acute myeloid leukemia (AML) from returning in adults who have had a stem cell transplant. About 366 participants will receive either mocravimod or a placebo alongside their standard transplant care. The main goal is t…
Phase: PHASE3 • Sponsor: Priothera SAS • Aim: Disease control
Last updated May 26, 2026 12:10 UTC